ArticleInternational dental journal2026
Effect of Caerin 1.9 Antimicrobial Peptide Gel on Early Bacterial Infections in Oral Titanium Implants: An Animal Study.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Immunological Features of Peri-Implant Soft Tissue After Healing Abutment Dislodgement: A Comparative Human Study.International dental journal · 2026Observational
- A Comparative Study of Caerin 1.1/1.9 and Calcium Hydroxide in the Treatment of Apical Periodontitis in Rats.International dental journal · 2026Article
- Caerin 1.1/1.9 peptides controlFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe current study aims to investigate the antibacterial potential of caerin 1.9 in the form of a thermo-sensitive gel for prevention and management of early postoperative infection of oral titanium metallic implants.
methodsTwenty-two New Zealand rabbits were randomly assigned to three groups: the F3 (caerin 1.9) group (n = 8), the control group (n = 8), and the blank group (n = 6). The early infection model of implant was established by implanting the micro-titanium nail after oral mixed bacteria drip into the mandible. The F3 group was given early intervention with caerin 1.9 at the same time, and the control group was given the same amount of PBS. The blank group underwent simulated surgical procedures without any treatment. Postoperative conditions were monitored, and local symptoms were evaluated. The bacterial load around the implants, peripheral blood white blood cell counts, and inflammatory responses in both soft and hard tissues were analyzed by HE staining.
resultsOn the 7th or 14th day post-surgery, the number of white blood cells, neutrophils, and lymphocytes, the content of inflammatory factors in soft tissue in the surgical area, the infiltration of inflammatory cells in bone tissue around the implantation cavity, and the total amount of bacteria around the implantation cavity in the F3 group were significantly lower than those in the control group (P < 0.05).
conclusionsCaerin 1.9 antibacterial peptide gel can reduce bacterial load, decrease inflammatory response, accelerate anti-inflammatory process, and prevent the occurrence of early implant infection. CLINICAL RELEVANCE: Caerin 1.9 antimicrobial peptide gel is a non-antibiotic strategy for preventing early-stage implant-related infections and a promising future adjunct to clinical implant materials for reducing bacterial adhesion and supporting early wound healing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.